Статті в журналах з теми "Vaccine elicited antibodies"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Vaccine elicited antibodies".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Willis, Elinor, Norbert Pardi, Kaela Parkhouse, Barbara L. Mui, Ying K. Tam, Drew Weissman, and Scott E. Hensley. "Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice." Science Translational Medicine 12, no. 525 (January 8, 2020): eaav5701. http://dx.doi.org/10.1126/scitranslmed.aav5701.
Повний текст джерелаGupta, Rajesh K., David N. Taylor, Dolores A. Bryla, John B. Robbins, and Shousun C. Szu. "Phase 1 Evaluation of Vibrio choleraeO1, Serotype Inaba, Polysaccharide-Cholera Toxin Conjugates in Adult Volunteers." Infection and Immunity 66, no. 7 (July 1, 1998): 3095–99. http://dx.doi.org/10.1128/iai.66.7.3095-3099.1998.
Повний текст джерелаGreaney, Allison J., Andrea N. Loes, Lauren E. Gentles, Katharine H. D. Crawford, Tyler N. Starr, Keara D. Malone, Helen Y. Chu, and Jesse D. Bloom. "Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection." Science Translational Medicine 13, no. 600 (June 8, 2021): eabi9915. http://dx.doi.org/10.1126/scitranslmed.abi9915.
Повний текст джерелаHarris, Shannon L., Adam Finn, and Dan M. Granoff. "Disparity in Functional Activity between Serum Anticapsular Antibodies Induced in Adults by Immunization with an Investigational Group A and C Neisseria meningitidis-Diphtheria Toxoid Conjugate Vaccine and by a Polysaccharide Vaccine." Infection and Immunity 71, no. 6 (June 2003): 3402–8. http://dx.doi.org/10.1128/iai.71.6.3402-3408.2003.
Повний текст джерелаNuñez, Ivette A., Ying Huang, and Ted M. Ross. "Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections." Pathogens 10, no. 11 (October 20, 2021): 1352. http://dx.doi.org/10.3390/pathogens10111352.
Повний текст джерелаKoeberling, Oliver, Isabel Delany, and Dan M. Granoff. "A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle Vaccines." Clinical and Vaccine Immunology 18, no. 5 (March 2, 2011): 736–42. http://dx.doi.org/10.1128/cvi.00542-10.
Повний текст джерелаSalat, Jiri, Petra Strakova, and Daniel Ruzek. "Dynamics of Whole Virus and Non-Structural Protein 1 (NS1) IgG Response in Mice Immunized with Two Commercial Tick-Borne Encephalitis Vaccines." Vaccines 10, no. 7 (June 23, 2022): 1001. http://dx.doi.org/10.3390/vaccines10071001.
Повний текст джерелаDapporto, Francesca, Serena Marchi, Margherita Leonardi, Pietro Piu, Piero Lovreglio, Nicola Decaro, Nicola Buonvino, et al. "Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination." Journal of Immunology Research 2022 (August 31, 2022): 1–9. http://dx.doi.org/10.1155/2022/4813199.
Повний текст джерелаWarner, Nikole L., and Kathryn M. Frietze. "Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1." Vaccines 9, no. 7 (July 2, 2021): 726. http://dx.doi.org/10.3390/vaccines9070726.
Повний текст джерелаGiles, Brendan M., Stephanie J. Bissel, Dilhari R. DeAlmeida, Clayton A. Wiley, and Ted M. Ross. "Antibody Breadth and Protective Efficacy Are Increased by Vaccination with Computationally Optimized Hemagglutinin but Not with Polyvalent Hemagglutinin-Based H5N1 Virus-Like Particle Vaccines." Clinical and Vaccine Immunology 19, no. 2 (December 21, 2011): 128–39. http://dx.doi.org/10.1128/cvi.05533-11.
Повний текст джерелаVisciano, Maria Luisa, Aakash Mahant Mahant, Carl Pierce, Richard Hunte, and Betsy C. Herold. "Antibodies Elicited in Response to a Single Cycle Glycoprotein D Deletion Viral Vaccine Candidate Bind C1q and Activate Complement Mediated Neutralization and Cytolysis." Viruses 13, no. 7 (June 30, 2021): 1284. http://dx.doi.org/10.3390/v13071284.
Повний текст джерелаHeile, Jens M., Yiu-Lian Fong, Domenico Rosa, Kim Berger, Giulietta Saletti, Susanna Campagnoli, Giuliano Bensi, et al. "Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates." Journal of Virology 74, no. 15 (August 1, 2000): 6885–92. http://dx.doi.org/10.1128/jvi.74.15.6885-6892.2000.
Повний текст джерелаWaickman, Adam T., Joseph Lu, Corey Chase, Hengsheng Fang, Erinn McDowell, Erin Bingham, Jeffrey Bogart, Stephen Graziano, Stephen J. Thomas, and Teresa Gentile. "Systemic Cancer Therapy Does Not Significantly Impact Early Vaccine-Elicited SARS-CoV-2 Immunity in Patients with Solid Tumors." Vaccines 10, no. 5 (May 9, 2022): 738. http://dx.doi.org/10.3390/vaccines10050738.
Повний текст джерелаHu, Mary C., Michael A. Walls, Steven D. Stroop, Mark A. Reddish, Bernard Beall, and James B. Dale. "Immunogenicity of a 26-Valent Group A Streptococcal Vaccine." Infection and Immunity 70, no. 4 (April 2002): 2171–77. http://dx.doi.org/10.1128/iai.70.4.2171-2177.2002.
Повний текст джерелаBasha, Saleem, Staci Hazenfeld, Rebecca Brady, and Ramu Subbramanian. "Domain-specific variation in hemagglutinin-specific T-cell responses elicited by licensed seasonal influenza vaccines (106.11)." Journal of Immunology 186, no. 1_Supplement (April 1, 2011): 106.11. http://dx.doi.org/10.4049/jimmunol.186.supp.106.11.
Повний текст джерелаChing, Lance K., Giorgos Vlachogiannis, Katherine A. Bosch, and Leonidas Stamatatos. "The First Hypervariable Region of the gp120 Env Glycoprotein Defines the Neutralizing Susceptibility of Heterologous Human Immunodeficiency Virus Type 1 Isolates to Neutralizing Antibodies Elicited by the SF162gp140 Immunogen." Journal of Virology 82, no. 2 (November 14, 2007): 949–56. http://dx.doi.org/10.1128/jvi.02143-07.
Повний текст джерелаChandrasekar, Shaswath S., Yashdeep Phanse, Rachel E. Hildebrand, Mostafa Hanafy, Chia-Wei Wu, Chungyi H. Hansen, Jorge E. Osorio, M. Suresh, and Adel M. Talaat. "Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization." Vaccines 9, no. 2 (February 6, 2021): 132. http://dx.doi.org/10.3390/vaccines9020132.
Повний текст джерелаTurner, Hannah L., Raiees Andrabi, Christopher A. Cottrell, Sara T. Richey, Ge Song, Sean Callaghan, Fabio Anzanello, et al. "Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization." Science Advances 7, no. 31 (July 2021): eabh2791. http://dx.doi.org/10.1126/sciadv.abh2791.
Повний текст джерелаMadani, Navid, Amy M. Princiotto, David Easterhoff, Todd Bradley, Kan Luo, Wilton B. Williams, Hua-Xin Liao, et al. "Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds." Journal of Virology 90, no. 10 (March 9, 2016): 5031–46. http://dx.doi.org/10.1128/jvi.03211-15.
Повний текст джерелаMurji, Amyn A., Juliana S. Qin, Tandile Hermanus, Lynn Morris, and Ivelin S. Georgiev. "Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms." Viruses 13, no. 7 (July 2, 2021): 1296. http://dx.doi.org/10.3390/v13071296.
Повний текст джерелаLian, Ying, Indresh Srivastava, V. Rául Gómez-Román, Jan zur Megede, Yide Sun, Elaine Kan, Susan Hilt, et al. "Evaluation of Envelope Vaccines Derived from the South African Subtype C Human Immunodeficiency Virus Type 1 TV1 Strain." Journal of Virology 79, no. 21 (November 1, 2005): 13338–49. http://dx.doi.org/10.1128/jvi.79.21.13338-13349.2005.
Повний текст джерелаMaciejewski, Sonia, Tracy J. Ruckwardt, Kaitlyn M. Morabito, Bryant M. Foreman, Katherine E. Burgomaster, David N. Gordon, Rebecca S. Pelc, et al. "Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality." Science Translational Medicine 12, no. 547 (June 10, 2020): eaaw9066. http://dx.doi.org/10.1126/scitranslmed.aaw9066.
Повний текст джерелаBryan, J. T., J. F. Smith, W. Ruiz, M. K. Brownlow, M. J. Brown, and M. T. Esser. "Evaluation of antibodies induced by an HPV vaccine to cross-neutralize pseudovirions of vaccine-related HPV types." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 15008. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.15008.
Повний текст джерелаDangi, Tanushree, Nicole M. Palacio, Sarah Sanchez, and Pablo Penaloza-MacMaster. "Characterization of cross-reactive immunity following coronavirus vaccination or natural infection." Journal of Immunology 206, no. 1_Supplement (May 1, 2021): 103.13. http://dx.doi.org/10.4049/jimmunol.206.supp.103.13.
Повний текст джерелаZost, Seth J., Kaela Parkhouse, Megan E. Gumina, Kangchon Kim, Sebastian Diaz Perez, Patrick C. Wilson, John J. Treanor, Andrea J. Sant, Sarah Cobey, and Scott E. Hensley. "Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains." Proceedings of the National Academy of Sciences 114, no. 47 (November 6, 2017): 12578–83. http://dx.doi.org/10.1073/pnas.1712377114.
Повний текст джерелаAbd Alla, Mohamed D., Gary L. White, Tyson B. Rogers, Max E. Cary, David W. Carey, and Jonathan I. Ravdin. "Adherence-Inhibitory Intestinal Immunoglobulin A Antibody Response in Baboons Elicited by Use of a Synthetic Intranasal Lectin-Based Amebiasis Subunit Vaccine." Infection and Immunity 75, no. 8 (May 25, 2007): 3812–22. http://dx.doi.org/10.1128/iai.00341-07.
Повний текст джерелаNeerukonda, Sabari Nath, Russell Vassell, Sabrina Lusvarghi, Richard Wang, Fernando Echegaray, Lisa Bentley, Ann E. Eakin, et al. "SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity." Viruses 13, no. 12 (December 11, 2021): 2485. http://dx.doi.org/10.3390/v13122485.
Повний текст джерелаNagashima, Kaito A., and Jarrod J. Mousa. "Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine." Viruses 13, no. 4 (March 24, 2021): 546. http://dx.doi.org/10.3390/v13040546.
Повний текст джерелаLuo, Deyan, Bing Ni, Peng Li, Wei Shi, Songle Zhang, Yue Han, Liwei Mao, Yangdong He, Yuzhang Wu, and Xiliang Wang. "Protective Immunity Elicited by a Divalent DNA Vaccine Encoding Both the L7/L12 and Omp16 Genes of Brucella abortus in BALB/c Mice." Infection and Immunity 74, no. 5 (May 2006): 2734–41. http://dx.doi.org/10.1128/iai.74.5.2734-2741.2006.
Повний текст джерелаPenezina, Oksana, Neil X. Krueger, Isaac R. Rodriguez-Chavez, Michael P. Busch, John Hural, Jerome H. Kim, Robert J. O'Connell, et al. "Performance of a Redesigned HIV Selectest Enzyme-Linked Immunosorbent Assay Optimized To Minimize Vaccine-Induced Seropositivity in HIV Vaccine Trial Participants." Clinical and Vaccine Immunology 21, no. 3 (January 8, 2014): 391–98. http://dx.doi.org/10.1128/cvi.00748-13.
Повний текст джерелаRiddle, Mark S., Robert W. Kaminski, Claudio Di Paolo, Chad K. Porter, Ramiro L. Gutierrez, Kristen A. Clarkson, Hailey E. Weerts, et al. "Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study." Clinical and Vaccine Immunology 23, no. 12 (August 31, 2016): 908–17. http://dx.doi.org/10.1128/cvi.00224-16.
Повний текст джерелаChou, Ai-Hsiang, Chia-Chyi Liu, Jui-Yuan Chang, Shu-Pei Lien, Meng-Shin Guo, Hau-Pong Tasi, Kuang-Nan Hsiao, et al. "Immunological Evaluation and Comparison of Different EV71 Vaccine Candidates." Clinical and Developmental Immunology 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/831282.
Повний текст джерелаMancini, Francesca, Francesca Micoli, and Omar Rossi. "Setup and Characterization of a High-Throughput Luminescence-Based Serum Bactericidal Assay (L-SBA) to Determine Functionality of Human Sera against Shigella flexneri." BioTech 11, no. 3 (July 27, 2022): 29. http://dx.doi.org/10.3390/biotech11030029.
Повний текст джерелаVerma, Anita, Miriam M. Ngundi, and Drusilla L. Burns. "Mechanistic Analysis of the Effect of Deamidation on the Immunogenicity of Anthrax Protective Antigen." Clinical and Vaccine Immunology 23, no. 5 (February 24, 2016): 396–402. http://dx.doi.org/10.1128/cvi.00701-15.
Повний текст джерелаSarker, Protim, Evana Akhtar, Rakib Ullah Kuddusi, Mohammed Mamun Alam, Md Ahsanul Haq, Md Biplob Hosen, Bikash Chandra Chanda, et al. "Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population." Vaccines 10, no. 9 (September 8, 2022): 1498. http://dx.doi.org/10.3390/vaccines10091498.
Повний текст джерелаArevalo, Claudia P., Marcus J. Bolton, Valerie Le Sage, Naiqing Ye, Colleen Furey, Hiromi Muramatsu, Mohamad-Gabriel Alameh, et al. "A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes." Science 378, no. 6622 (November 25, 2022): 899–904. http://dx.doi.org/10.1126/science.abm0271.
Повний текст джерелаKamei, Akinobu, Yamara S. Coutinho-Sledge, Joanna B. Goldberg, Gregory P. Priebe, and Gerald B. Pier. "Mucosal Vaccination with a Multivalent, Live-Attenuated Vaccine Induces Multifactorial Immunity againstPseudomonas aeruginosaAcute Lung Infection." Infection and Immunity 79, no. 3 (December 13, 2010): 1289–99. http://dx.doi.org/10.1128/iai.01139-10.
Повний текст джерелаHuang, Ying, Monique S. França, James D. Allen, Hua Shi, and Ted M. Ross. "Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection." Vaccines 9, no. 7 (July 16, 2021): 793. http://dx.doi.org/10.3390/vaccines9070793.
Повний текст джерелаCheng, Cheng, Jason G. D. Gall, Martha Nason, C. Richter King, Richard A. Koup, Mario Roederer, M. Juliana McElrath, et al. "Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization." Journal of Virology 84, no. 1 (October 21, 2009): 630–38. http://dx.doi.org/10.1128/jvi.00866-09.
Повний текст джерелаNelson, Cody S., Tori Huffman, Jennifer A. Jenks, Eduardo Cisneros de la Rosa, Guanhua Xie, Nathan Vandergrift, Robert F. Pass, Justin Pollara, and Sallie R. Permar. "HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions." Proceedings of the National Academy of Sciences 115, no. 24 (April 30, 2018): 6267–72. http://dx.doi.org/10.1073/pnas.1800177115.
Повний текст джерелаHatano, Kazue, and Gerald B. Pier. "Complex Serology and Immune Response of Mice to Variant High-Molecular-Weight O Polysaccharides Isolated fromPseudomonas aeruginosa Serogroup O2 Strains." Infection and Immunity 66, no. 8 (August 1, 1998): 3719–26. http://dx.doi.org/10.1128/iai.66.8.3719-3726.1998.
Повний текст джерелаYahalom-Ronen, Yfat, Noam Erez, Morly Fisher, Hadas Tamir, Boaz Politi, Hagit Achdout, Sharon Melamed та ін. "Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera". Vaccines 10, № 2 (14 лютого 2022): 291. http://dx.doi.org/10.3390/vaccines10020291.
Повний текст джерелаCarter, Donald M., Christopher A. Darby, Bradford C. Lefoley, Corey J. Crevar, Timothy Alefantis, Raymond Oomen, Stephen F. Anderson, et al. "Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses." Journal of Virology 90, no. 9 (February 24, 2016): 4720–34. http://dx.doi.org/10.1128/jvi.03152-15.
Повний текст джерелаGreaney, Allison J., Rachel T. Eguia, Tyler N. Starr, Khadija Khan, Nicholas Franko, Jennifer K. Logue, Sandra M. Lord, et al. "The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes." PLOS Pathogens 18, no. 6 (June 29, 2022): e1010592. http://dx.doi.org/10.1371/journal.ppat.1010592.
Повний текст джерелаdel Valle, Jorge Reyes, Patricia Devaux, Gregory Hodge, Nicholas J. Wegner, Michael B. McChesney, and Roberto Cattaneo. "A Vectored Measles Virus Induces Hepatitis B Surface Antigen Antibodies While Protecting Macaques against Measles Virus Challenge." Journal of Virology 81, no. 19 (July 18, 2007): 10597–605. http://dx.doi.org/10.1128/jvi.00923-07.
Повний текст джерелаGalula, Jedhan U., Chung-Yu Yang, Brent S. Davis, Gwong-Jen J. Chang, and Day-Yu Chao. "Cross-reactivity reduced dengue virus 2 vaccine has no cross-protection against heterotypic dengue viruses." Future Virology 15, no. 2 (February 2020): 79–90. http://dx.doi.org/10.2217/fvl-2019-0115.
Повний текст джерелаMichon, Pascal, Tresa Fraser, and John H. Adams. "Naturally Acquired and Vaccine-Elicited Antibodies Block Erythrocyte Cytoadherence of the Plasmodium vivaxDuffy Binding Protein." Infection and Immunity 68, no. 6 (June 1, 2000): 3164–71. http://dx.doi.org/10.1128/iai.68.6.3164-3171.2000.
Повний текст джерелаWang, Hongye, Zengshuai Wang, Liang Ma, Xiaoyong Zhu, Bingxiang Li, Yuhang Huang, Jingwen Li, Ming Sun, Li Shi, and Yufeng Yao. "S Trimer Derived from SARS-CoV-2 B.1.351 and B.1.618 Induced Effective Immune Response against Multiple SARS-CoV-2 Variants." Vaccines 11, no. 1 (January 16, 2023): 193. http://dx.doi.org/10.3390/vaccines11010193.
Повний текст джерелаChen, Shing C., David H. Jones, Ellen F. Fynan, Graham H. Farrar, J. Christopher S. Clegg, Harry B. Greenberg, and John E. Herrmann. "Protective Immunity Induced by Oral Immunization with a Rotavirus DNA Vaccine Encapsulated in Microparticles." Journal of Virology 72, no. 7 (1998): 5757–61. http://dx.doi.org/10.1128/jvi.72.7.5757-5761.1998.
Повний текст джерелаLijeskić, Olivera, Ivana Klun, Marija Stamenov Djaković, Nenad Gligorić, Tijana Štajner, Jelena Srbljanović, and Olgica Djurković-Djaković. "Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim Report." Vaccines 9, no. 9 (September 17, 2021): 1031. http://dx.doi.org/10.3390/vaccines9091031.
Повний текст джерела